Zobrazeno 1 - 10
of 1 536
pro vyhledávání: '"Mouret S"'
Autor:
Niveau C; Institute for Advanced Biosciences, Team: Epigenetics, Immunity, Metabolism, Cell Signaling & Cancer, Inserm U 1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.; R&D Laboratory, Etablissement Français du Sang Auvergne-Rhône-Alpes, Grenoble, France., Sosa Cuevas E; Institute for Advanced Biosciences, Team: Epigenetics, Immunity, Metabolism, Cell Signaling & Cancer, Inserm U 1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.; R&D Laboratory, Etablissement Français du Sang Auvergne-Rhône-Alpes, Grenoble, France., Roubinet B; GLYcoDiag, Orléans, France., Pezet M; Institute for Advanced Biosciences, Plateforme de Microscopie Photonique-Imagerie Cellulaire et Cytométrie en Flux (Microcell), Inserm U1209-CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France., Thépaut M; Institut de Biologie Structurale, Université Grenoble Alpes, CNRS, CEA, Grenoble, France., Mouret S; Dermatology, Allergology & Photobiology Department, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France., Charles J; Dermatology, Allergology & Photobiology Department, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France., Fieschi F; Institut de Biologie Structurale, Université Grenoble Alpes, CNRS, CEA, Grenoble, France.; Institut Universitaire de France (IUF), Paris, France., Landemarre L; GLYcoDiag, Orléans, France., Chaperot L; Institute for Advanced Biosciences, Team: Epigenetics, Immunity, Metabolism, Cell Signaling & Cancer, Inserm U 1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.; R&D Laboratory, Etablissement Français du Sang Auvergne-Rhône-Alpes, Grenoble, France., Saas P; Institute for Advanced Biosciences, Team: Epigenetics, Immunity, Metabolism, Cell Signaling & Cancer, Inserm U 1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.; R&D Laboratory, Etablissement Français du Sang Auvergne-Rhône-Alpes, Grenoble, France., Aspord C; Institute for Advanced Biosciences, Team: Epigenetics, Immunity, Metabolism, Cell Signaling & Cancer, Inserm U 1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.; R&D Laboratory, Etablissement Français du Sang Auvergne-Rhône-Alpes, Grenoble, France.
Publikováno v:
Immunology [Immunology] 2024 Feb; Vol. 171 (2), pp. 286-311. Date of Electronic Publication: 2023 Nov 22.
Autor:
Connell E; Dermatology and Skin Cancer Department, Aix Marseille University, APHM, CRCM Inserm U1068, CNRS U7258, Marseille, France.; Department of Early Phase Cancer Trial Center (CEPCM) 'CLIP2,' Aix Marseille University, APHM, Marseille, France., Gerard É; Dermatology Department, CHU de Bordeaux, Bordeaux, France., Oules B; Dermatology Department, Cochin Hospital, Paris, France., Brunet-Possenti F; Dermatology Department, Bichat Claude-Bernard Hospital, Paris, France., Lamoureux A; Dermatology Department, Montpellier Cancer Institute, Montpellier, France., Bonnefille H; Dermatology Department, CHU de Nîmes, Nîmes, France., Mary-Prey S; Dermatology Department, CHU de Bordeaux, Bordeaux, France., Carrasquilla A; Dermatology Department, Leon Bérard Cancer Center, Lyon, France., Mouret S; Dermatology Department, CHU Grenoble Alpes, University Grenoble Alpes, INSERM U 1209, CNRS UMR 5309, Institut for Advanced Biosciences, Grenoble, France., Kramkimel N; Dermatology Department, Cochin Hospital, Paris, France., Lesage C; Dermatology Department, CHU de Montpellier, Montpellier, France., Stoebner PE; Dermatology Department, CHU de Nîmes, Nîmes, France., Bartoli A; Radiology Department, Aix Marseille University, APHM, CERIMED, Marseille, France., Monestier S; Dermatology and Skin Cancer Department, Aix Marseille University, APHM, CRCM Inserm U1068, CNRS U7258, Marseille, France.; Department of Early Phase Cancer Trial Center (CEPCM) 'CLIP2,' Aix Marseille University, APHM, Marseille, France., Correard F; Pharmacy Department, Aix Marseille University, APHM, Marseille, France., Gros A; Tumor Biology and Tumor Bank Department, University Hospital of Bordeaux, Bordeaux, France., Jeanson A; Department of Early Phase Cancer Trial Center (CEPCM) 'CLIP2,' Aix Marseille University, APHM, Marseille, France.; Multidisciplinary Oncology and Therapeutic Innovations Department, Aix Marseille University, CNRS, INSERM, CRCM, APHM, Marseille, France., Ouafik L; Oncobiology Department, Aix Marseille University, APHM, CNRS, INP, Inst Neurophysiopathol, Marseille, France., Gaudy-Marqueste C; Dermatology and Skin Cancer Department, Aix Marseille University, APHM, CRCM Inserm U1068, CNRS U7258, Marseille, France.; Department of Early Phase Cancer Trial Center (CEPCM) 'CLIP2,' Aix Marseille University, APHM, Marseille, France., Tomasini P; Department of Early Phase Cancer Trial Center (CEPCM) 'CLIP2,' Aix Marseille University, APHM, Marseille, France.; Multidisciplinary Oncology and Therapeutic Innovations Department, Aix Marseille University, CNRS, INSERM, CRCM, APHM, Marseille, France., Charles J; Dermatology Department, CHU Grenoble Alpes, University Grenoble Alpes, INSERM U 1209, CNRS UMR 5309, Institut for Advanced Biosciences, Grenoble, France., Amini-Adle M; Dermatology Department, Leon Bérard Cancer Center, Lyon, France., Malissen N; Dermatology and Skin Cancer Department, Aix Marseille University, APHM, CRCM Inserm U1068, CNRS U7258, Marseille, France.; Department of Early Phase Cancer Trial Center (CEPCM) 'CLIP2,' Aix Marseille University, APHM, Marseille, France.
Publikováno v:
The oncologist [Oncologist] 2024 Sep 06; Vol. 29 (9), pp. e1180-e1188.
Autor:
Marxgut L; Department of Radiation Oncology, CHU Grenoble Alpes, avenue Maquis-du-Grésivaudan, 38700 La Tronche, France. Electronic address: lmarxgut@chu-grenoble.fr., Desagneaux A; Department of Radiation Oncology, CHU Grenoble Alpes, avenue Maquis-du-Grésivaudan, 38700 La Tronche, France., Bellier A; Department of Dermatology, CHU Grenoble Alpes, avenue Maquis-du-Grésivaudan, 38700 La Tronche, France., Mouret S; Department of Clinical Investigation Research, CHU Grenoble Alpes, avenue Maquis-du-Grésivaudan, 38700 La Tronche, France., Charles J; Department of Clinical Investigation Research, CHU Grenoble Alpes, avenue Maquis-du-Grésivaudan, 38700 La Tronche, France., Laramas M; Department of Oncology, CHU Grenoble Alpes, avenue Maquis-du-Grésivaudan, 38700 La Tronche, France., Verry C; Department of Radiation Oncology, CHU Grenoble Alpes, avenue Maquis-du-Grésivaudan, 38700 La Tronche, France.
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [Cancer Radiother] 2024 Aug 21. Date of Electronic Publication: 2024 Aug 21.
Autor:
Castillo-Ferrer C; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Grenoble Alpes University, Grenoble, France; École Pratique des Hautes Études, PSL Research University, Paris, France., Marguet T; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Grenoble Alpes University, Grenoble, France; Dermatology, Allergology & Photobiology Department, Grenoble Alpes University Hospital, Grenoble Alpes University, Grenoble, France., Vanwonterghem L; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Grenoble Alpes University, Grenoble, France., Erbek S; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Grenoble Alpes University, Grenoble, France; École Pratique des Hautes Études, PSL Research University, Paris, France., Chuffart F; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Grenoble Alpes University, Grenoble, France., Mouret S; Dermatology, Allergology & Photobiology Department, Grenoble Alpes University Hospital, Grenoble Alpes University, Grenoble, France., Messai ST; Dermatology, Allergology & Photobiology Department, Grenoble Alpes University Hospital, Grenoble Alpes University, Grenoble, France., Gauchez AS; Biology and Pathology Institute, Grenoble Alpes University Hospital, Grenoble Alpes University, Grenoble, France., Coll JL; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Grenoble Alpes University, Grenoble, France., Charles J; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Grenoble Alpes University, Grenoble, France; Dermatology, Allergology & Photobiology Department, Grenoble Alpes University Hospital, Grenoble Alpes University, Grenoble, France., Hurbin A; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Grenoble Alpes University, Grenoble, France. Electronic address: amandine.hurbin@inserm.fr., Martel-Frachet V; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Grenoble Alpes University, Grenoble, France; École Pratique des Hautes Études, PSL Research University, Paris, France.
Publikováno v:
The Journal of investigative dermatology [J Invest Dermatol] 2024 Feb; Vol. 144 (2), pp. 422-426.e8. Date of Electronic Publication: 2023 Aug 12.
Autor:
Skowron, F., Seigneurin, A., Mouret, S., Khammari, A., Charles, J., Leccia, M.-T., RIC-Mel Network
Publikováno v:
In EJC Skin Cancer 2024 2 Supplement 1
Autor:
Mouret, S., Gaudriault, P.
Publikováno v:
In Psychologie francaise 2011 56(1):45-57
Autor:
Dubus M; Dermatology Department, Grenoble Alpes University Hospital, La Tronche, France., Charles J; Dermatology Department, Grenoble Alpes University Hospital, La Tronche, France., Leccia MT; Dermatology Department, Grenoble Alpes University Hospital, La Tronche, France., Mouret S; Dermatology Department, Grenoble Alpes University Hospital, La Tronche, France., Trabelsi S; Dermatology Department, Grenoble Alpes University Hospital, La Tronche, France.
Publikováno v:
JAAD case reports [JAAD Case Rep] 2023 Jun 08; Vol. 38, pp. 14-16. Date of Electronic Publication: 2023 Jun 08 (Print Publication: 2023).
Autor:
Mouret, S., Brun, E., Gil, H., Adam, J.F., Villanova, J., Dubus, M., Olivier, C., Tardieu, M., Templier, I., Hubiche, T., Cardot-Leccia, N., Bazot, K., Singh, S., Charles, J., Bayat, S., Chosidow, O., Leccia, M.T.
Publikováno v:
In Annales de Dermatologie et de Vénéréologie - FMC December 2023 3(8) Supplement 1:A187-A187
Autor:
Sosa Cuevas E; Institute for Advanced Biosciences, Team: Epigenetics, Immunity, Metabolism, Cell Signaling and Cancer, Inserm U 1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.; Etablissement Français du Sang Auvergne-Rhône-Alpes, R&D Laboratory, Grenoble, France., Roubinet B; GLYcoDiag, Orléans, France., Mouret S; Dermatology, Allergology and Photobiology Department, CHU Grenoble Alpes, Grenoble, France., Thépaut M; Université Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale, Grenoble, France., de Fraipont F; Medical Unit of Molecular Genetic (Hereditary Diseases and Oncology), Grenoble University Hospital, Grenoble, France., Charles J; Dermatology, Allergology and Photobiology Department, CHU Grenoble Alpes, Grenoble, France., Fieschi F; Université Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale, Grenoble, France.; Institut Universitaire de France (IUF), Paris, France., Landemarre L; GLYcoDiag, Orléans, France., Chaperot L; Institute for Advanced Biosciences, Team: Epigenetics, Immunity, Metabolism, Cell Signaling and Cancer, Inserm U 1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.; Etablissement Français du Sang Auvergne-Rhône-Alpes, R&D Laboratory, Grenoble, France., Aspord C; Institute for Advanced Biosciences, Team: Epigenetics, Immunity, Metabolism, Cell Signaling and Cancer, Inserm U 1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.; Etablissement Français du Sang Auvergne-Rhône-Alpes, R&D Laboratory, Grenoble, France.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Feb 20; Vol. 14, pp. 1120434. Date of Electronic Publication: 2023 Feb 20 (Print Publication: 2023).
Publikováno v:
In Planetary and Space Science 2008 56(14):1819-1822